Sassicaia Capital Advisers »

Ropanc Biopharma shares owned by Sassicaia Capital Advisers

Quarter-by-quarter ownership of Ropanc Biopharma (PPCB) shares owned by Sassicaia Capital Advisers from 13F filings

Historical chart of Sassicaia Capital Advisers investment in Ropanc Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ropanc Biopharma held by Sassicaia Capital Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ropanc Biopharma by Sassicaia Capital Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.7k 16k 0.11

More positions owned by Sassicaia Capital Advisers

Spdr Gold Tr Gold Shs (GLD)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Sandisk Corp (SNDK)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Marvell Technology (MRVL)
Exxon Mobil Corporation (XOM)
Chevron Corporation (CVX)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Occidental Petroleum Corporation (OXY)
Apa Corporation (APA)
Tesla Motors (TSLA)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Caesars Entertainment (CZR)

View all positions for Sassicaia Capital Advisers

Top funds holding Ropanc Biopharma

UBS Group
Jane Street
Marex Group
XTX Topco
Sassicaia Capital Advisers

View all funds holding Ropanc Biopharma